Posterior reversible encephalopathy syndrome after long-term treatment with low-dose sunitinib: a case report

Neurol Sci. 2017 Jun;38(6):1119-1121. doi: 10.1007/s10072-017-2851-7. Epub 2017 Feb 21.

Authors

Lorenzo Saraceno¹, Vito A G Ricigliano¹, Michele Cavalli¹, Giovanni Meola²

Affiliations

¹ Department of Biomedical Sciences for Health, University of Milan, IRCCS Policlinico San Donato, Piazza E. Malan 1, 20097, San Donato Mil.se (Milan), Italy.
² Department of Biomedical Sciences for Health, University of Milan, IRCCS Policlinico San Donato, Piazza E. Malan 1, 20097, San Donato Mil.se (Milan), Italy. giovanni.meola@unimi.it.

PMID: 28224329
DOI: 10.1007/s10072-017-2851-7

No abstract available

Keywords: Anti-VEGF therapy; Hypertension; Posterior reversible encephalopathy syndrome; Sunitinib.

Publication types

Case Reports
Letter

MeSH terms

Aged
Angiogenesis Inhibitors / adverse effects*
Female
Humans
Hypertension / drug therapy
Magnetic Resonance Imaging
Occipital Lobe / diagnostic imaging
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / diagnostic imaging
Sunitinib / adverse effects*

Substances

Angiogenesis Inhibitors
Sunitinib